Us2.v1 vs KardiaPro

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Us2.v1

by eko.ai Pte. Ltd. d/b/a Us2.ai

KardiaPro

by AliveCor

AI Verdict

Us2.v1 is designed for fully automated echocardiography analysis, providing comprehensive reports and disease detection in real-time to enhance workflow efficiency in cardiology. KardiaPro, on the other hand, focuses on remote patient monitoring, offering a web-based portal for managing ECG, blood pressure, and weight data with AI-powered arrhythmia detection to support ongoing patient care and trend analysis. While both tools leverage AI in cardiology and are FDA-cleared, Us2.v1 specializes in echo analysis, whereas KardiaPro excels in remote patient data monitoring.

Choose Us2.v1 if…

Choose Us2.v1 if your primary need is fully automated, rapid, and comprehensive analysis of echocardiography studies. This tool excels at generating structured reports with measurements and disease detection (e.g., cardiac amyloidosis, pulmonary hypertension, heart failure) in seconds, significantly improving workflow efficiency and diagnostic accuracy in a clinical setting.

View Us2.v1 →

Choose KardiaPro if…

Choose KardiaPro if your focus is on remote, continuous monitoring of patient cardiac data, including ECG, blood pressure, and weight, between appointments. This web-based portal, integrated with personal ECG devices like KardiaMobile, is ideal for managing chronic cardiac conditions, detecting arrhythmias, analyzing trends, and making informed clinical decisions for improved patient care outside of traditional office visits.

View KardiaPro →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Us2.v1	KardiaPro
Pricing	Volume-based pricing model.	Contact for pricing
Deployment	Cloud, On-premise, Hybrid solution	Cloud-hosted, Web-based
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Us2.v1

Us2.v1 emphasizes 'zero-click analysis' and 'real-time processing (results in seconds),' suggesting a highly automated and efficient workflow that significantly reduces manual effort and time for echocardiography analysis. While KardiaPro offers a customizable inbox and automated summary reports, it still requires patient interaction with a device and subsequent data review by professionals, which implies more steps in the user workflow.

Clinical Value

Us2.v1

Us2.v1 provides comprehensive, fully automated echocardiography analysis, including measurements and disease detection for conditions like cardiac amyloidosis and pulmonary hypertension, with results comparable to expert human measurements. KardiaPro focuses on remote monitoring of ECG, blood pressure, and weight data with AI for arrhythmia detection, which is valuable for ongoing patient management but less comprehensive in its diagnostic scope compared to Us2.v1's detailed echo analysis.

Pricing & Value

Tie

Both tools use a 'contact for pricing' model, making a direct comparison of cost-effectiveness difficult. Us2.v1 uses a 'volume-based pricing model,' and KardiaPro mentions being 'reimbursable using existing CPTu00ae codes,' but neither provides transparent pricing details. Without specific pricing information or detailed cost-benefit analyses for comparable use cases, it's not possible to definitively declare a winner in this dimension.

Enterprise Readiness

Us2.v1

Us2.v1 offers flexible deployment options including cloud, on-premise, and hybrid solutions, and is compatible with any PACS, CVIS, or EMR system, making it highly adaptable to various enterprise IT infrastructures. KardiaPro is cloud-hosted and web-based, integrating with KardiaMobile devices and supporting EHR interoperability, but its deployment flexibility appears less extensive than Us2.v1's.

Innovation

Us2.v1

Us2.v1 demonstrates significant innovation with its 'zero-click,' fully automated echocardiography analysis that generates comprehensive reports in seconds, a substantial leap in automating a traditionally manual and time-consuming process. KardiaPro's innovation lies in its comprehensive remote patient monitoring platform and FDA-cleared AI for arrhythmia detection, which is impactful for chronic disease management but represents a more established area of digital health.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer specific details regarding the depth, availability, or quality of support and documentation for either Us2.v1 or KardiaPro. Both companies are established in their respective fields, suggesting a baseline level of support, but without explicit information, a definitive winner cannot be chosen.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Us2.v1	KardiaPro
Tool Name	Us2.v1	KardiaPro
Company	eko.ai Pte. Ltd. d/b/a Us2.ai	AliveCor
Description	Provides FDA-cleared, fully automated AI software for echocardiography analysis, generating comprehensive structured reports with measurements and disease detection in seconds, significantly improving workflow efficiency and diagnostic accuracy.	A comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. It provides a secure platform to manage and review data between appointments, making it easy for healthcare professionals to analyze trends and make informed clinical decisions for improved patient care.
Key Features	Fully automated echocardiography analysis, Zero-click analysis, Real-time processing (results in seconds), Comprehensive structured reports (measurements, disease detection, findings), Editable annotations and conclusions, Comparison to international reference guidelines, Automated detection of cardiac amyloidosis, Automated detection of pulmonary hypertension	Comprehensive web-based portal for remote monitoring, ECG, blood pressure, and weight data management, FDA-cleared AI for arrhythmia detection, Customizable ECG inbox for efficient data review, Automated summary reports and trend visualization, Seamless integration with KardiaMobile and KardiaMobile 6L devices, Integration with KardiaStation for point-of-care solutions, HIPAA-compliant and SOC-2 certified data handling
Specialties	Cardiology	Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Us2.v1 and KardiaPro.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How deeply can Us2.v1 and KardiaPro integrate with existing EHR systems and what is the impact on physician workflow?

Us2.v1 integrates with any PACS, CVIS, or EMR via standard DICOM routing, with results delivered as DICOM-SR, HL7, or PDF, aiming for zero workflow disruption as it runs in the background and provides a pre-populated draft report for the cardiologist's final sign-off. KardiaPro integrates with EHR systems, including Epic via its App Orchard Marketplace, allowing providers to seamlessly prescribe and access remote ECG monitoring data within existing workflows. This integration allows for automated pulling of ECGs into the EHR and supports interoperability with third-party systems through SDK/API configurations.

What is the accuracy and sensitivity of each tool in detecting cardiac conditions relevant to my practice?

Us2.v1 offers fully automated echocardiography analysis, providing comprehensive structured reports with measurements and disease detection, including cardiac amyloidosis, pulmonary hypertension, aortic stenosis, and heart failure. Its automated measurements have been shown to be interchangeable with expert human measurements and are completely reproducible. KardiaPro utilizes FDA-cleared AI for arrhythmia detection, including AFib, bradycardia, tachycardia, and normal sinus rhythm, with advanced determinations detecting additional abnormalities like Sinus Rhythm with PVCs, SVE, and Wide QRS. Studies have shown high sensitivity and specificity for AFib detection, comparable to expert cardiology over-reads.

What is the typical learning curve for physicians and their staff to effectively use Us2.v1 and KardiaPro, and what kind of support is available?

Us2.v1 is designed for zero workflow disruption, fitting into existing infrastructure without requiring new views or steps for sonographers, and the cardiologist retains final sign-off on the editable reports. KardiaPro is a web-based portal designed to streamline remote patient monitoring, with features like a customizable ECG inbox and automated summary reports to aid efficient data review. Both companies offer support, with Us2.ai providing ongoing monitoring and support after a typical 4-week deployment. KardiaPro provides user guides and resources for patient connections and reporting.

Beyond HIPAA, what additional security measures and certifications do Us2.v1 and KardiaPro have in place to protect patient data?

Us2.v1 maintains ISO 13485 and ISO 27001:2022 certifications for medical device quality management and information security, as well as SOC 2 Type II attestation, GDPR compliance, and MDSAP. KardiaPro is SOC-2 certified and ISO 27001 certified, in addition to being HIPAA compliant, demonstrating a commitment to high standards of data security and compliance. Both tools emphasize robust security postures that go beyond HIPAA to protect sensitive health information.

Can I get customer references or case studies demonstrating successful multi-site rollouts and sustained value for either Us2.v1 or KardiaPro?

Us2.v1 has been deployed in various markets globally, including the US, UK, Europe, Canada, Australia, New Zealand, and Singapore, and has shown to reduce echocardiogram reporting time significantly in clinical deployments. KardiaPro is utilized by healthcare professionals for remote patient monitoring and integrates with devices like KardiaMobile 6L, which is widely adopted and doctor-recommended. While specific multi-site rollout case studies are not detailed, both companies highlight their commitment to improving clinical workflows and patient care.

What audit-trail features are available in Us2.v1 and KardiaPro to ensure accountability and support clinical governance?

Us2.v1 provides transparent AI annotations where every result is traceable and fully editable by the clinician, ensuring that clinical authority stays with the physician. The system also offers audit logging for core lab solutions. KardiaPro allows for the management and review of patient data, including ECGs, with features like a customizable inbox and automated summary reports, which inherently support a reviewable trail of patient information and physician interpretations.

In what clinical contexts would a physician choose Us2.v1 over KardiaPro, or vice-versa, considering their distinct functionalities?

A physician would choose Us2.v1 for automated, comprehensive echocardiography analysis, particularly for diagnosing and monitoring conditions like heart failure, cardiac amyloidosis, pulmonary hypertension, and valvular disease, where detailed structural and functional cardiac measurements are critical. Conversely, KardiaPro would be the preferred choice for remote patient monitoring focused on ECG, blood pressure, and weight data, especially for efficient arrhythmia detection and long-term cardiac rhythm management outside of traditional office settings.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Us2.v1 or KardiaPro

Backers

Who funded each tool's parent company.